TJ Ferrante was quoted in a Part B News article, “Four Areas Where Telehealth, Though Under-Covered, Can Bring in Revenue,” which discusses the top four medical spaces aside from Medicare where telehealth services have the greatest revenue-building potential.
Ferrante was quoted numerous times throughout the article, sharing his experience in and forecasts for each of the four spaces. For example, he explained that within Medicare Advantage and Medicaid managed care, the plans “are encouraged to develop new and innovative ways to provide care and are generally subject to fewer restrictions of telehealth services.”
Ferrante continues to serve as a primary source, discussing revenue from telehealth as it also relates to concierge medicine, new technology and patients who are willing to travel for services post-telehealth consultation.
Ferrante was quoted numerous times throughout the article, sharing his experience in and forecasts for each of the four spaces. For example, he explained that within Medicare Advantage and Medicaid managed care, the plans “are encouraged to develop new and innovative ways to provide care and are generally subject to fewer restrictions of telehealth services.”
Ferrante continues to serve as a primary source, discussing revenue from telehealth as it also relates to concierge medicine, new technology and patients who are willing to travel for services post-telehealth consultation.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”